View more. Resistance level for the month, calculated based on price range of the Disclosures under Reg. Volume Weighted Average Price represents the average price of a security over a particular time period (example one trading day) weighted by the volume traded at each price point. Focus back on active pharmaceutical ingredients. Pharmaceutical major Sun Pharma’s share price surged 4.2% on Friday morning despite the weaker sentiment in the domestic equity markets, which were down close to 1%. 84,503.87. Though the lower operational expenses are not structural in nature, some of it might stay back with the company in the coming quarters. | It remains to be seen if this trend will continue in the post COVID-19 period also. Digital technologies are being leveraged significantly for patient-to-doctor connect currently since a face-to-face consultation may not be possible due to COVID-19. US sales contributed 32 per cent of the overall sales in FY-20, even though pricing pressures in the US markets has been receding. ICICI Securities has given a buy rating to Sun Pharma with a target price of Rs 550. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011. Sun Pharmaceutical Industries Ltd. share price forecast The 47 reports from 13 analysts offering long term price targets for Sun Pharmaceutical Industries Ltd. have an average target of 573.42. [{"heading":"Revenue","data":[{"year":"Sep 2019","value":"8123","formattedValue":"8,123 Cr"},{"year":"Dec 2019","value":"8154","formattedValue":"8,154 Cr"},{"year":"Mar 2020","value":"8184","formattedValue":"8,184 Cr"},{"year":"Jun 2020","value":"7585","formattedValue":"7,585 Cr"},{"year":"Sep 2020","value":"8553","formattedValue":"8,553 Cr"}]},{"heading":"Net Profit","data":[{"year":"Sep 2019","value":"1167","formattedValue":"1,167 Cr"},{"year":"Dec 2019","value":"1023","formattedValue":"1,023 Cr"},{"year":"Mar 2020","value":"494","formattedValue":"494 Cr"},{"year":"Jun 2020","value":"-2429","formattedValue":"-2,429 Cr"},{"year":"Sep 2020","value":"1948","formattedValue":"1,948 Cr"}]},{"heading":"EPS","data":[{"year":"Jun 2019","value":"4.43","formattedValue":"4.43"},{"year":"Mar 2019","value":"5.78","formattedValue":"5.78"},{"year":"Dec 2020","value":"1.67","formattedValue":"1.67"},{"year":"Jun 2020","value":"7.56","formattedValue":"7.56"},{"year":"Mar 2020","value":"-6.90","formattedValue":"-6.90"}]}], {"success":1,"data":{"address":{"address1":"Sun Pharma Advanced Research Centre (SPA","address2":"Tandalja,,","city":"Vadodra","state":"Gujarat","pincode":"390020","telephone1":"0265-6615500","telephone2":"0265-6615600","fax1":"0265-2354897","fax2":"","email":"secretarial@sunpharma.com","web":"http:\/\/www.sunpharma.com"},"management":[{"name":"Israel Makov","designation":"Chairman"},{"name":"Dilip S Shanghvi","designation":"Managing Director"},{"name":"Sailesh T Desai","designation":"Whole Time Director"},{"name":"Kalyanasundaram Subramanian","designation":"Whole Time Director"},{"name":"Sudhir V Valia","designation":"Non Exe.Non Ind.Director"}],"registrars":{"name":"Link Intime India Pvt. based on price range of the previous trading week. SUN PHARMA Share Price Today: SUN PHARMA last traded price was up 3.8% to Rs 568.9 on the BSE. Dr Reddys Labs. Any one suggest for tomorrow movement. Meanwhile, the BSE HEALTHCARE Index is at 19,607 (up 1.1%).. represents current trend. Discover historical prices for SUNPHARMA.NS stock on Yahoo Finance. based on price range of the previous trading month. Cipla Ltd. is a Public company that was founded in 1935 in Mumbai, Maharashtra. Get Sun Pharma stock rating based on quaterly result, profit and loss account, balance sheet, shareholding pattern and annual report. Dividend Yield calculates the amount of full year dividend declared by a company as a percentage of the current market price of a stock. As on 30-09-2020, the company has a total of 2,399,334,970 shares outstanding. All timestamps are reflected in IST (Indian Standard Time). The share price moved up by 0.26 per cent from its previous close of Rs 513.85. Arvind Sir what do you say about HDFC life? Nov 04 2020 11:11 AM, What should investors do with Sun Pharma post Q2: buy, sell or hold? Company has S R B C & Co. LLP as its auditors. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express writtern permission of moneycontrol.com is prohibited. (Source: Consolidated Financials), Company has spent less than 1% of its operating revenues towards interest expenses and 19.38% towards employee cost in the year ending Mar 31, 2020. (as of last trading session), Sun Pharmaceutical Industries Ltd., incorporated in the year 1993, is a Large Cap company (having a market cap of Rs 136450.18 Crore) operating in Pharmaceuticals sector. The drug firm's stock was trading close to its 52-week high of Rs 480, touched on April 10, 2019. Sun Pharmaceuticals stock: Why analysts are bullish on this share now - 23 Nov 2020 SUN PHARMA Share Price Up by 5%; BSE HEALTHCARE Index Up 1.3% - 2 day(s) ago Ask Ajit: 'Help! This unique "area" or candle chart enables you to clearly notice the movements of this Sun Pharma share within the last hours of trading, as well as providing you with key data such as the daily change, high and low prices. Stock with consistent financial performance, quality management, and strong technical momentum indicating good investor enthusiasm. View more, PHARMA sector me abhi kaafi scope hai so use dip and buy for 600. The Prices page of Sun Pharmaceutical Industries Ltd.. captures the information on Price and Volume for a user defined time interval. Note : Support and Resistance level for the ... Gold Bank of Baroda IndusInd Bank share price Gold rate today Tesla stock price Bank holidays in November 2020 Radhakishan Damani TCS share price SBI share price RCom share price YES Bank share price RIL share price. Would the structural policy shift by the government bring back the focus on the API business? DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. Buy Sun Pharma, target price Rs 600: Motilal Oswal, Buy Sun Pharma, target price Rs 610: Motilal Oswal, All figures in Rs Cr, unless mentioned otherwise, MANAGEMENT DISCUSSION AND ANALYSIS (FY 2019-20), Digital technologies - In post covid world, will it or will it not. Stock market update: 160 stocks hit 52-week highs on NSE, Stock market update: Pharma stocks advance; Cadila Healthcare leaps 6%, D-Street veteran Ramesh Damani shares his magic formula for stock picking. The dividend declared by a company is usually declared as a percentage of face value. Operating Profit Margin (TTM) - Company's Operating Profit Margin growth at -0.15% v/s Industry growth of -0.08%, Price to Book Ratio - Above industry Median, Revenue Growth (TTM) - Company's Revenue growth at 3.43% v/s Industry growth of 4.24%, Profit Growth (TTM) - Company's Profit growth at -61.44% v/s Industry growth of -8.48%, TTM PEG Ratio - Negative PEG TTM Price to Earnings Growth, FII/FPI have decreased holdings from 12.7% to 12.38% in Sep 2020 qtr, Promoter holding remains unchanged at 54.69% as on Sep 2020 qtr, Promoter pledges decreased from 10.35% to 9.09% in Sep 2020 qtr. You will now receive notification when someone reply to this message. Higher the market capitalization of a company, higher the rank it is assigned. Stock saw 46 number of Large Deals today. Experts view is that the stock showed immediate buying from lower levels in this session. It also contains the Live Stock Price and Volume, 52 Week High Low, Bid and Offer Price and Volume, Intraday and Historical Price Chart. This is a ratio arrived at by dividing the current market price of a stock by its latest (annual or annualized) earnings per share. Currently Sun Pharmaceuticals is trading lower than yesterday, which is not good for the stock. Note : Support and Resistance level for the month, calculated Sun Pharmaceutical Industries Ltd., incorporated in the year 1993, is a Large Cap company (having a market cap of Rs 121430.34 Crore) operating in Pharmaceuticals sector. Sun Pharma share price live updates on The Economic Times. India is uniquely positioned as a crucial supplier of pharmaceuticals by way of chemistry expertise, lower personnel costs and the ability to manufacture quality medicines in compliance with global regulatory standards. Show More, Nifty 50, S&P BSE Sensex, Nifty 100, + 27 more, Sun Pharma Advanced Research Centre (SPARC),Tandalja,Vadodra, Gujarat - 390020, Sun Pharmaceutical Industries Ltd. share price moved down by -2.34% from its previous close of Rs 582.30. Bonus History (Sun Pharmaceutical Industries) Get edge to your technical analysis with Advanced chart with 100+ technical indicators, tools and studies with various chart types. Book value is also known as Net Asset Value of a company. View more Note : Support and Resistance level for the week, calculated Promoters remains unchanged at 54.69% in Sep 2020 qtr. SUNPHARMA Expiry Date 31DEC2020: As on 04-DEC-2020 15:59:54 Hours IST : Calls: Puts: Quote : Open Interest: Change in Open Interest: LTP: Net Change: Volume: Bid Marg, Vikhroli (West), Take informed investment decision with advanced AI based features like SWOT Analysis, Investment checklist, Technical rating & Trends and know how fairly the company is valued, Insightful analysis on stocks for price performance, financials, Piotroski score, Shareholdings and compare company’s performing within industry averages, Get actionable recommendations and read research reports, Investors presentation and listen to earnings call transcripts, Historical trends of FII, DII, MF & Promoter holdings along with pledge details. Stay updated with latest Block and Bulk deal and keep an eye on what Insiders are doing in stock. All other things being equal, higher the dividend yield of the stock, the better it is for investors. Promoters pledge decreased from 10.35% to 9.09% of holdings in qtr. The company’s top management includes Mr.Dilip S Shanghvi, Mr.Gautam Doshi, Mr.Israel Makov, Mr.Kalyanasundaram Subramanian, Mr.Sailesh T Desai, Mr.Sudhir V Valia, Mr.Vivek Chaand Sehgal, Ms.Rekha Sethi. Bullish / Bearish signals for Sun Pharmaceutical Industries Ltd. basis selected technical indicators and moving average crossovers. Average price gain of 6.72% within 7 weeks of Bullish signal in last 10 years, Stock gave a 3 year return of 11.58% as compared to Nifty 100 which gave a return of 26.45%. Any one suggest for tomorrow movement. Indian pharma industry has some inherent strength. Check out why Sun Pharma share price is up today. Pharmaceutical spending in the top five Western European (WE5) markets is projected to grow at about 3-6% CAGR to US$210-240 Billion by 2024. DR. LAL PATHLABS (down 0.2%) and TORRENT PHARMA (down 0.2%) are among the top losers today.. Over the last one year, SUN PHARMA has moved up from Rs 438 to Rs … *Disclosures under SEBI Prohibition of Insider Trading Regulations, 2015, *Disclosures under SEBI SAST (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. Currently valued at Good to expensive valuation. We recommend buy trade which could be profitable for a price target of 584.83 with a … PHARMA sector me abhi kaafi scope hai so use dip and buy for 600 Its showing heavy buying in today's intra day trading! ICICI Prudential Bluechip Fund Direct-Growth, Mirae Asset Emerging Bluechip Fund Direct-Growth. Resistance level for the week, calculated based on price range of the Buy Sun Pharma, target price Rs 610: Motilal Oswal . Get Live Sun Pharmaceutical Industries stock market chart. *A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions. Arvind Sir what do you say about HDFC life? C 101, 247 Park, (Source: Consolidated Financials). Fundamental, Stock Ideas, Multibaggers & Insights, Stock & Index F&O Trading Calls & Market Analysis, Positional and Intraday Trading Calls basis Noiseless Chart, Commodity Trading Calls & Market Analysis, Currency Derivatives Trading Calls & Insights, Options Trading Advice and Market Analysis, Model portfolios, Investment Ideas, Guru Screens and Much More, Proprietary system driven Rule Based Trading calls, Curated markets data, exclusive trading recommendations, Independent equity analysis & actionable investment ideas, Details stock report and investment recommendation, (OI Check Sun Pharma share price, financial data and complete stock analysis. The last bonus that Sun Pharmaceutical Industries had announced was in 2013 in the ratio of 1:1. The total volume of shares traded was 16.6 m. Overall, the broader S&P BSE HEALTHCARE Index was up by 0.9%. It is also the 1 year high and low of the security. Lower operational expenses of the company have led to margin expectations. This Sun Pharmaceutical Industries Ltd. key Products/Revenue Segments include Pharmaceuticals which contributed Rs 11906.74 Crore to Sales Value (95.01 % of Total Sales) and Other Operating Revenue which contributed Rs 625.19 Crore to Sales Value (4.98 % of Total Sales)for the year ending 31-Mar-2020.For the quarter ended 30-09-2020, the company has reported a Consolidated sales of Rs 8458.77 Crore, up 13.28 % from last quarter Sales of Rs 7467.19 Crore and up 6.41 % from last year same quarter Sales of Rs 7949.19 Crore Company has reported net profit after tax of Rs 1948.38 Crore in latest quarter.The company’s top management includes Mr.Dilip S Shanghvi, Mr.Gautam Doshi, Mr.Israel Makov, Mr.Kalyanasundaram Subramanian, Mr.Sailesh T Desai, Mr.Sudhir V Valia, Mr.Vivek Chaand Sehgal, Ms.Rekha Sethi. Sun Pharma Share – Conclusion. The stock’s last traded price is Rs 507.25. ), Strong Performer: This is the ranking of a company within its sector based on MCap or Market capitalization. Earnings per share (TTM) tells the profit after tax earned on a per share basis by a stock over the last twelve months or four quarters. Number of Mutual Funds remains unchanged at 43 in Sep 2020 qtr, Bullish Momentum - Above Short, Medium and Long Term Moving Averages, Outperformer - Sun Pharmaceutical Industries up by 11.7% v/s NIFTY 50 up by 9.21% in last 1 month. Note: Close price will be updated after 18.15 hrs on account of joint press release dated February 09, 2018 (joint press release) On Ex-Date, the % change is calculated with respect to Adjusted price (adjustment with respect to Corporate Actions such as Dividend, Bonus, Rights & Face Value Split) 5,514.65. Intraday sentiment of Sun Pharmaceuticals is towards buying. Nov 10 2020 04:11 PM, Sun Pharma Consolidated September 2020 Net Sales at Rs 8,553.13 crore, up 5.29% Y-o-Y Sun Pharma Advanced Research Centre (SPA,Tandalja,. Sun Pharmaceuticals share price Low made is about 1.04% below the opening. Intraday forecast of Sun Pharmaceuticals is towards buy and stock might move higher. Copyright © e-Eighteen.com Ltd. All rights reserved. Sun Pharma has 30,000 employees and is ranked 1st among it's top 10 competitors. Find the latest SUN PHARMACEUTICAL (SUNPHARMA.NS) stock quote, history, news and other vital information to help you with your stock trading and investing. Sun Pharmaceutical Industries view the board of directors and their designations of the various companies, the name of the chairman and the name of the company secretary. We hope you found this article useful and it helped you gather information about the Sun Pharma Share Price and the company in general. 5. Launch of new-age specialty products will drive this growth. The consensus estimate represents an upside of 0.77% from the last price of 569.05. For the year ending March 2020 Sun Pharmaceutical Industries has declared an equity dividend of 400.00% amounting to Rs 4 per share. This is a ratio of market capitalisation of a company’s stock to its annual sales. The market capitalization here is taken for the fully paid-up equity share of the company. What should investors do with Sun Pharma post Q2: buy, sell or hold? Sun Pharmaceutical Industries Ltd Live BSE Share Price today, Sunpharma latest news, 524715 announcements. The Economic Times; Nov 26, 2020 00:00 previous trading month. 5,082.35. Free Sun Pharma Historic stock charts for NSE / BSE. 2,497.60. day, calculated based on price range of the previous trading day. Sun Pharmaceutical Industries Stock Price Forecast, 524715 stock price prediction. Get details of MF schemes and name of institutions invested in company. Company analysis giving insights of fundamentals, earnings, relative valuations, risk, price momentum and inside trading. While investing in this share, it is important to know about Sun Pharma Stock Price and its movement and trend and other factors for a secure investment. Sun Pharmaceuticals SUNPHARMA share price forecast & targets for short-term is a uptrend, and nearest possible share price target is 601.1 The share price is currently trading at 569.05 However, if the trend reverses from this point, then a possible future share price target could be 553 The stock’s last traded price is Rs 515.30. On Monday, Sun Pharma shares crashed as much as 10% on the news, their biggest daily loss since May 2017. Copyright © 2020 Bennett, Coleman & Co. Ltd. All rights reserved. On the NSE, SUN PHARMA last traded price was up 3.8% to Rs 569.1. View daily, weekly … Note : Support and 0.54. Tomorrow's share price targets for Sun Pharmaceuticals Industries Limited are 579.57 and 590.08 on the upside . Business Standard News: Price History: Sun Pharmaceuticals Industries (SUNPHARMA) - Business Standard News and more from Business Standard News | Page 1 The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. 2018-19 Annual Report Download Complete Annual Report (4.74 MB) , PRICE This represents the highest and lowest price touched by the security during the past 52 weeks or 1 year including today. And the benchmark S&P BSE SENSEX was at 45,079.6 (up 1.0%). Sun Pharmaceutical Industries Ltd., incorporated in the year 1993, is a Large Cap company (having a market cap of Rs 121430.34 Crore) operating in Pharmaceuticals sector. DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. Thomson Reuters proprietary rating of stock on scale of 1 to 10, Industry ranking and detailed sector analysis of recent happening in sector, Analyst rating like Buy/Sell/Hold with Earnings estimates with 1 year price target. Note : Support and Resistance level for the Here we have taken the TTM (trailing twelve months) adjusted earnings per share. Price to Book represents the ratio of current market price of a stock to its book value per share. More share price targets here - Intraday, weekly and monthly price targets Short-term, Long-term forecast for Sun Pharmaceuticals Industries Limited NEWS for Sun Pharmaceuticals Industries Limited Closing Cash & Cash Equivalent Growth (%), Book closure from Aug 21, 2020 to Aug 27, 2020, Bonus Ratio: 1 share(s) for every 1 shares held, Bonus Ratio: 2 share(s) for every 1 shares held. SUN PHARMA share price has zoomed 5% and is presently trading at Rs 511.. Face value of a stock is the value ascribed to the stock as per the balance sheet of the company. L.B.S. (Source: Consolidated Financials), Company will take 1.16 years to pay off its debt obligations with latest operating cash flow of Rs 6554.77 cr. Old MCI!~!172@29@0@53!~!|commonstore|commonfiles|moneycontrol_header.php?cid=0&s_cid=0&radar_off=1&is_revamped_header=1&is_responsive=1&sec=&priceinter=1&frommc=1&is_hardcoded_dfp=1&device_type=desktop&page_id=mc_pricechart_homepage_new!~!www|moneycontrol|com!~!|commonstore|commonfiles|moneycontrol_header.php!~!is_mobile=false. The share price moved up by 0.18 per cent from its previous close of Rs 506.35. Low share price is about -89% of the candle stick body. Sun Pharmaceutical Industries Ltd. stock last traded price is 568.70, Sun Pharmaceutical Industries Ltd. share price moved down by -2.36% from its previous close of Rs 582.30. Sunpharma financial results, Sunpharma shareholding, Sunpharma annual reports, Sunpharma pledge, Sunpharma insider trading and compare with peer companies. Higher the score, better the financials of the company. This represents the 52 week high and low price of the security. Intraday targets for sellers are 501.00, 495.87, and 490.74 and sellers of Sun Pharmaceuticals can take an entry below 506.13 (Source: Consolidated Financials), Company has used Rs 2588.84 cr for investing activities which is an YoY increase of 280.01%. Book value represents the value arrived at by subtracting the total liabilities from the total assets of the company. Government led price control initiatives to improve patient access is likely to act as a counter-balancing force to this growth. The top 10 competitors average 17,847. Nov 12 2020 12:11 PM, Why Lupinu2019s Solosec is a cautionary tale for the much-hyped speciality drug business Let's reshape it today, Hunt for the brightest engineers in India. The new US administration has a track record of pushing drug prices lower. It will continue to be an important player in the global generics market. The stock hit an over six-month low and was the top decliner on NSE. previous trading week. Piotroski F-Score determines the financial strength of the company and ranges between 0 to 9. day, calculated based on price range of the previous trading day. Currently valued at Good to expensive valuation, Strong Performer: For the quarter ended 30-09-2020, the company has reported a Consolidated sales of Rs 8458.77 Crore, up 13.28 % from last quarter Sales of Rs 7467.19 Crore and up 6.41 % from last year same quarter Sales of Rs 7949.19 Crore Company has reported net profit after tax of Rs 1948.38 Crore in latest quarter. *Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore. Among the top Gainers in the BSE HEALTHCARE Index today is SUN PHARMA (up 5.1%). Access our live advanced streaming chart forSun Pharmaceutical Industries Ltd. Share, free of charge. Sun Pharmaceutical Industries Ltd., incorporated in the year 1993, is a Large Cap company (having a market cap of Rs 123301.82 Crore) operating in Pharmaceuticals sector. Nifty may touch 13,640 by December 2021: Nomura Shares of Sun Pharmaceuticals Industries were trading higher for the fourth straight day, up 8.5 per cent to Rs 474 on the BSE on Thursday on expectation of improvement in the company's outlook. Company's annual revenue growth of 11.24% outperformed its 3 year CAGR of 1.57%. can we invest? Self Declaration Format for Non-Resident Shareholders. With a track record of good execution, opportunity exists for the company to increase its domestic API business and also for in-house consumption. Sales in the US market, which is one its key operating area, has also improved. Stock with consistent financial performance, quality management, and strong technical momentum indicating good investor enthusiasm. For reprint rights: Sun Pharmaceutical Industries Ltd., incorporated in the year 1993, is a Large Cap company (having a market cap of Rs 136450.18 Crore) operating in Pharmaceuticals sector. Copyright © e-Eighteen.com Ltd All rights resderved. Mutual Funds have increased holdings from 10.52% to 10.71% in Sep 2020 qtr. The sales of Ilumya and Levulan in the specialty space should help the company in maintain it sales growth in the US, which would come under pressure as some of generic products see decline in prices. Increasing overall market size but pricing pressure might continue. Nov 04 2020 10:11 AM, What about tommorow for Sun pharmacy? Sun Pharmaceutical Industries Ltd. stock last traded price is 568.55. Motilal Oswal has given a buy rating to Sun Pharma with a target price of Rs 610. (as of last trading session), Stock generated 11.58% return as compared to Nifty Pharma which gave investors 37.87% return over 3 year time period. Sun Pharma offers a program for individuals who want to disclose violations of US FDA requirements related to facilities or products owned or operated by Ranbaxy prior to Sun Pharma's acquisition of Ranbaxy. If you wish to learn more about the program, please click Continue. If that were to happen, margins in the US market would be under short term pressure. can we invest? Note : Support and Get detailed Sun Pharma stock price news and analysis, Dividend, Bonus Issue, Quarterly results information, and more. Ltd.","address1":"C 101, 247 Park,\nL.B.S. Sun Pharmaceutical Industries Ltd. key Products/Revenue Segments include Pharmaceuticals which contributed Rs 11906.74 Crore to Sales Value (95.01 % of Total Sales) and Other Operating Revenue which contributed Rs 625.19 Crore to Sales Value (4.98 % of Total Sales)for the year ending 31-Mar-2020. The book value itself is arrived at by dividing the net worth of a company by the total number of shares outstanding of the company at that time. No Data For Substantial Acquisition of Shares & Takeovers. By using this site, you agree to the Terms of Service and Privacy Policy. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express writtern permission of moneycontrol.com is prohibited. Previous candle stick is a bullish candle, with a length of 9.35% . The share has been quoting ex-bonus from July 29, 2013. Company has S R B C & Co. LLP as its auditors. Sensex rallies 506 pts on buying in RIL, IT stocks; Nifty tops 13,100; Sun Pharma jumps 6%, IndusInd Bank 5%. Tomorrow is different. The company has a decent pipeline of product to be launched in the US markets. As on 30-09-2020, the company has a total of 2,399,334,970 shares outstanding. On dividing this value with the total number of shares outstanding for the company, we can arrive at book value per share. MCap or Market capitalization of a stock is calculated by multiplying the total number of shares outstanding of that particular stock with its current market price. Cipla Ltd. is Sun Pharma's #1 competitor. Aditya Birla Sun Life Tax Relief 96 Direct-Growt.. Marg, Vikhroli (West)","address2":"","address3":"","address4":"","telephone":"022-49186270, 49186200","fax":"022-49186060","email":"rnt.helpdesk@linkintime.co.in","internet":"http:\/\/www.linkintime.co.in","city":"Mumbai","state":"Maharashtra","pincode":"400083"},"listing":[{"name":"BSE 100","value":"Yes"},{"name":"BSE 200","value":"Yes"},{"name":"SENSEX","value":"Yes"},{"name":"CNX MIDCAP 200","value":"No"},{"name":"NIFTY 50","value":"Yes"},{"name":"BSE 500","value":"Yes"}],"details":{"bseId":"524715","nseId":"SUNPHARMA","series":"EQ","isinid":"INE044A01036"}}}, Old MCI!~!172@29@0@53!~!|commonstore|commonfiles|moneycontrol_footer.php?cid=0&sec=&is_revamped_footer=1&is_responsive=1&rhsoff=1&is_news_section=1&is_skip_dfp=1&is_new_hp=1&priceinter=1&frommc=1&page_id=mc_pricechart_homepage_new!~!www|moneycontrol|com!~!|commonstore|commonfiles|moneycontrol_footer.php!~!is_mobile=false, Sensex breaches 45k mark; 8 index stocks hit 52-week high, Nifty may touch 13,640 by December 2021: Nomura, Why Lupinu2019s Solosec is a cautionary tale for the much-hyped speciality drug business, Sun Pharma Consolidated September 2020 Net Sales at Rs 8,553.13 crore, up 5.29% Y-o-Y.

sun pharma share price

Bream Carp Hybrid, Concorde Take Off; Sonic Boom, Osha 10 Training Online, Exalted Lord Of Change Rules, Age Beautiful 8rc, Washing Machine Parts And Accessories, Writing Portfolio Examples,
sun pharma share price 2020